A医药公司经营者激励与约束研究

发布时间：2018-03-16 22:01

本文选题：A医药公司　切入点：经营者激励　出处：《郑州大学》2017年硕士论文　论文类型：学位论文

【摘要】：A医药公司是国有控股医药商业企业,创建于20世纪50年代。历经60余年的发展,目前是某大型医药集团下属医药板块重点企业。该公司经营万余种药品,主要业务为医疗终端配送、商业分销、社会零售终端等。近年来,A医药公司的销售业绩逐年上涨,取得了长足的发展,然而,随着该公司的不断发展和市场竞争的加剧,经营者激励与约束问题凸现,如经营者薪酬水平低、结构不合理、绩效考核缺乏激励性、约束机制和权责发生制没有形成等。这些问题都严重制约着A医药公司的发展。如何从整体上建立有效的经营者激励模式与约束机制,是A医药公司目前亟待解决的问题。本文在查阅大量文献资料的基础上,以经营者激励为理论依据,借鉴国有企业经营者的激励手段和激励模式,系统地研究A医药公司经营者激励与约束。首先,基于我国国有企业的经营者的激励模式,分析A医药公司经营者激励与约束的现状,揭示该公司经营者激励与约束中存在的问题,其次,通过物质激励如绩效激励、薪酬激励和精神激励如认可激励、职业成长与发展设计和工作与生活平衡、企业福利等多种激励方式,设计A医药公司经营者激励模式。进而,通过绩效考核方法、任职与绩效合同的契约约束等,提供A医药公司经营者约束机制。本文特色与创新之处主要表现在:(1)在分析A医药公司经营者激励与约束的现状的基础上,揭示该公司存在的经营者激励与约束问题及成因;(2)对A医药公司经营者激励进行整体设计,采用了绩效激励、薪酬激励、认可激励、职业成长与发展设计和工作与生活平衡、企业福利等多种激励方式;(3)提供了A医药公司经营者绩效考核与薪酬激励等约束机制。本文的研究将不仅为A医药公司提供一套可操作的经营者激励模式,而且将为其他医药公司经营者激励提供理论依据与分析途径。
[Abstract]:A Pharmaceutical Company is a state-owned holding pharmaceutical commercial enterprise, founded in 1950s. After more than 60 years of development, it is a major pharmaceutical sector enterprise under a large pharmaceutical group. The company operates more than 10,000 kinds of drugs. The main business is medical terminal distribution, commercial distribution, social retail terminal, etc. In recent years, the sales performance of A pharmaceutical company has increased year by year, and it has made great progress. However, with the continuous development of the company and the intensification of market competition, The problems of incentive and restriction of managers are obvious, such as low salary level, unreasonable structure, lack of incentive in performance appraisal, These problems seriously restrict the development of A pharmaceutical company. How to set up an effective incentive mode and constraint mechanism for managers as a whole, It is an urgent problem for A pharmaceutical company to solve. Based on consulting a lot of literature, this paper draws lessons from the incentive means and incentive mode of state-owned enterprise managers, based on the theoretical basis of operator incentive. First of all, based on the incentive mode of the managers of the state-owned enterprises in China, the paper analyzes the current situation of the managers' incentives and constraints in A pharmaceutical companies. Secondly, through material incentives such as performance incentives, compensation incentives and spiritual incentives such as recognition incentives, career growth and development design and work-life balance. The incentive mode of managers in A pharmaceutical company is designed, such as enterprise welfare, etc. Furthermore, through the performance appraisal method, the contract restriction between the position and the performance contract, etc. The main features and innovations of this paper are as follows: (1) on the basis of analyzing the current situation of incentive and restriction of A pharmaceutical company's managers, This paper reveals the problems and causes of manager incentive and restriction in this company. (2) the whole design of manager incentive in A pharmaceutical company is carried out, which adopts performance incentive, salary incentive, approbation incentive, career growth and development design and work-life balance. This paper will not only provide a set of operable incentive mode for A pharmaceutical company, but also provide a set of performance evaluation and compensation incentive mechanism for A pharmaceutical company. And will provide the theoretical basis and the analysis way for the other medicine company operator incentive.
【学位授予单位】：郑州大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：F272.92;F426.72

【相似文献】